Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US

Completed · Phase 4 · Has a placebo group

Conditions studied: Gastroesophageal Reflux Disease

In brief

The purpose of this research study is to compare the safety and effectiveness (how well the medicine works) of esomeprazole (study drug) to placebo (a capsule that does not contain any medication) taken daily in relieving nighttime heartburn and problems sleeping in patients with gastroesophageal reflux disease (GERD).

Key facts

Study ID
NCT00660660
Run by
AstraZeneca
People needed
276
Starts
2008-04-01
Expected to finish
2008-07-01
Last updated by the study team
2015-03-02

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.